A mosaic influenza virus-like particles vaccine provides broad humoral and cellular immune responses against influenza A viruses

被引:11
|
作者
Liu, Xuejie [1 ]
Zhao, Tianyi [1 ]
Wang, Liangliang [1 ]
Yang, Zhuolin [1 ]
Luo, Chuming [1 ]
Li, Minchao [1 ]
Luo, Huanle [1 ]
Sun, Caijun [1 ]
Yan, Huacheng [2 ]
Shu, Yuelong [1 ,3 ]
机构
[1] Sun Yat Sen Univ, Sch Publ Hlth Shenzhen, Shenzhen 518107, Peoples R China
[2] Ctr Dis Control & Prevent Southern Mil Theatre, Guangzhou 510507, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Inst Pathogen Biol, Beijing 100730, Peoples R China
关键词
T-CELLS; B-CELL; UNITED-STATES; PROTECTION; HEMAGGLUTININ; ANTIBODIES; EPITOPES; NEURAMINIDASE; INFECTION; CORRELATE;
D O I
10.1038/s41541-023-00728-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The development of a universal influenza vaccine to elicit broad immune responses is essential in reducing disease burden and pandemic impact. In this study, the mosaic vaccine design strategy and genetic algorithms were utilized to optimize the seasonal influenza A virus (H1N1, H3N2) hemagglutinin (HA) and neuraminidase (NA) antigens, which also contain most potential T-cell epitopes. These mosaic immunogens were then expressed as virus-like particles (VLPs) using the baculovirus expression system. The immunogenicity and protection effectiveness of the mosaic VLPs were compared to the commercial quadrivalent inactivated influenza vaccine (QIV) in the mice model. Strong cross-reactive antibody responses were observed in mice following two doses of vaccination with the mosaic VLPs, with HI titers higher than 40 in 15 of 16 tested strains as opposed to limited cross HI antibody levels with QIV vaccination. After a single vaccination, mice also show a stronger level of cross-reactive antibody responses than the QIV. The QIV vaccinations only elicited NI antibodies to a small number of vaccine strains, and not even strong NI antibodies to its corresponding vaccine components. In contrast, the mosaic VLPs caused robust NI antibodies to all tested seasonal influenza virus vaccine strains. Here, we demonstrated the mosaic vaccines induces stronger cross-reactive antibodies and robust more T-cell responses compared to the QIV. The mosaic VLPs also provided protection against challenges with ancestral influenza A viruses of both H1 and H3 subtypes. These findings indicated that the mosaic VLPs were a promising strategy for developing a broad influenza vaccine in future.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] A mosaic influenza virus-like particles vaccine provides broad humoral and cellular immune responses against influenza A viruses
    Xuejie Liu
    Tianyi Zhao
    Liangliang Wang
    Zhuolin Yang
    Chuming Luo
    Minchao Li
    Huanle Luo
    Caijun Sun
    Huacheng Yan
    Yuelong Shu
    [J]. npj Vaccines, 8
  • [2] Mosaic H5 Hemagglutinin Provides Broad Humoral and Cellular Immune Responses against Influenza Viruses
    Kamlangdee, Attapon
    Kingstad-Bakke, Brock
    Osorio, Jorge E.
    [J]. JOURNAL OF VIROLOGY, 2016, 90 (15) : 6771 - 6783
  • [3] Intranasal vaccination with M2e5x virus-like particles induces humoral and cellular immune responses conferring cross-protection against heterosubtypic influenza viruses
    Lee, Young-Tae
    Ko, Eun-Ju
    Lee, Youri
    Kim, Ki-Hye
    Kim, Min-Chul
    Lee, Yu-Na
    Kang, Sang-Moo
    [J]. PLOS ONE, 2018, 13 (01):
  • [4] Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers
    Tacket, CO
    Sztein, MB
    Losonsky, GA
    Wasserman, SS
    Estes, MK
    [J]. CLINICAL IMMUNOLOGY, 2003, 108 (03) : 241 - 247
  • [5] Vaccination with dengue virus-like particles induces humoral and cellular immune responses in mice
    Zhang, Shuo
    Liang, Mifang
    Gu, Wen
    Li, Chuan
    Miao, Fang
    Wang, Xiaofang
    Jin, Cong
    Zhang, Li
    Zhang, Fushun
    Zhang, Quanfu
    Jiang, Lifang
    Li, Mengfeng
    Li, Dexin
    [J]. VIROLOGY JOURNAL, 2011, 8
  • [6] Vaccination with dengue virus-like particles induces humoral and cellular immune responses in mice
    Shuo Zhang
    Mifang Liang
    Wen Gu
    Chuan Li
    Fang Miao
    Xiaofang Wang
    Cong Jin
    Li Zhang
    Fushun Zhang
    Quanfu Zhang
    Lifang Jiang
    Mengfeng Li
    Dexin Li
    [J]. Virology Journal, 8
  • [7] Neuraminidase expressing virus-like particle vaccine provides effective cross protection against influenza virus
    Kim, Ki-Hye
    Lee, Young-Tae
    Park, Soojin
    Jung, Yu-Jin
    Lee, Youri
    Ko, Eun-Ju
    Kim, Yu-Jin
    Li, Xuguang
    Kang, Sang-Moo
    [J]. VIROLOGY, 2019, 535 : 179 - 188
  • [8] Evaluation of influenza virus-like particles and Novasorne adjuvant as candidate vaccine for avian influenza
    Pushko, Peter
    Tumpey, Terrence M.
    Van Hoeven, Neal
    Belser, Jessica A.
    Robinson, Robin
    Nathan, Margret
    Smith, Gale
    Wright, D. Craig
    Bright, Rick A.
    [J]. VACCINE, 2007, 25 (21) : 4283 - 4290
  • [9] Humoral and cellular immune responses to influenza vaccine in patients with advanced cirrhosis
    Cheong, HJ
    Song, JY
    Park, JW
    Yeon, JE
    Byun, KS
    Lee, CH
    Cho, H
    Kim, TG
    Kim, WJ
    [J]. VACCINE, 2006, 24 (13) : 2417 - 2422
  • [10] Enhancement of mucosal immune responses by chimeric influenza HA/SHIV virus-like particles
    Guo, LZ
    Lu, XY
    Kang, SM
    Chen, CY
    Compans, RW
    Yao, QZ
    [J]. VIROLOGY, 2003, 313 (02) : 502 - 513